Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic

<abstract language="eng">It is the specific treatment of mansoni schistosomiasis that aims to act directed on the parasite, through chemotherapy. Constitutes fundamental indication to the treatment of schistosomiasis active forms, that is, these determined by the presence of living e...

Full description

Bibliographic Details
Main Author: Aloisio Sales da Cunha
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 1992-01-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000800055
_version_ 1797704697159614464
author Aloisio Sales da Cunha
author_facet Aloisio Sales da Cunha
author_sort Aloisio Sales da Cunha
collection DOAJ
description <abstract language="eng">It is the specific treatment of mansoni schistosomiasis that aims to act directed on the parasite, through chemotherapy. Constitutes fundamental indication to the treatment of schistosomiasis active forms, that is, these determined by the presence of living eggs in the feces or in material from rectal biopsy, since eventual contra indications are respected. Two are the medicaments actually used: oxamniquine, used in the single dosage of 15mg/kg, V.O. for adults and 20mg/kg V.O. for children divided in two doses, offers a percentage of 30 to 40% of cures, evaluated by quantitative "oogram" and prazinquantel, in the single dose of 60 mg/kg V.O., presents a cure index of 30% however in seriate doses, of 60mg/kg during 3 days or 30mg/kg, 6 days, cure percentage is elevated to 95% evaluated by oogram. The evaluation of the treatment by quantitative or qualitative examination methods does not show the same sensibility. The percentage of cure according to feces examination, the quantitative of Kato-Katz or the qualitative (sedimentation), showed indexes from 90 to 100% for either one of the drugs, even in single dose, which evidences the difference of methodology of therapeutic evaluation. Tolorance to both medicaments is from good to regular, with collateral effects in 30 to 40% of the patients.
first_indexed 2024-03-12T05:24:18Z
format Article
id doaj.art-f4dfed62fb324c5c8a34a4b78be9c4af
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T05:24:18Z
publishDate 1992-01-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-f4dfed62fb324c5c8a34a4b78be9c4af2023-09-03T07:27:15ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80601992-01-018734135110.1590/S0074-02761992000800055Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeuticAloisio Sales da Cunha<abstract language="eng">It is the specific treatment of mansoni schistosomiasis that aims to act directed on the parasite, through chemotherapy. Constitutes fundamental indication to the treatment of schistosomiasis active forms, that is, these determined by the presence of living eggs in the feces or in material from rectal biopsy, since eventual contra indications are respected. Two are the medicaments actually used: oxamniquine, used in the single dosage of 15mg/kg, V.O. for adults and 20mg/kg V.O. for children divided in two doses, offers a percentage of 30 to 40% of cures, evaluated by quantitative "oogram" and prazinquantel, in the single dose of 60 mg/kg V.O., presents a cure index of 30% however in seriate doses, of 60mg/kg during 3 days or 30mg/kg, 6 days, cure percentage is elevated to 95% evaluated by oogram. The evaluation of the treatment by quantitative or qualitative examination methods does not show the same sensibility. The percentage of cure according to feces examination, the quantitative of Kato-Katz or the qualitative (sedimentation), showed indexes from 90 to 100% for either one of the drugs, even in single dose, which evidences the difference of methodology of therapeutic evaluation. Tolorance to both medicaments is from good to regular, with collateral effects in 30 to 40% of the patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000800055chemotherapyoxamniquinetherapeutic evaluation
spellingShingle Aloisio Sales da Cunha
Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
Memorias do Instituto Oswaldo Cruz
chemotherapy
oxamniquine
therapeutic evaluation
title Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
title_full Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
title_fullStr Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
title_full_unstemmed Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
title_short Esquistossomose mansoni: tratamento medicamentoso Schistosomiasis mansoni: drug therapeutic
title_sort esquistossomose mansoni tratamento medicamentoso schistosomiasis mansoni drug therapeutic
topic chemotherapy
oxamniquine
therapeutic evaluation
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000800055
work_keys_str_mv AT aloisiosalesdacunha esquistossomosemansonitratamentomedicamentososchistosomiasismansonidrugtherapeutic